Literature DB >> 23388340

[Expression and clinicopathological significance of GRAMD4 in hepatocellular carcinoma].

Jing Zhang1, Kangsheng Tu, Zhenyu Zhou, Xin Zheng, Jie Gao, Yingmin Yao, Qingguang Liu.   

Abstract

OBJECTIVE: To investigate the expression of GRAMD4 and its correlation with the clinicopathological features in hepatocellular carcinoma (HCC).
METHODS: We freshly collected 40 samples of surgically resected paired HCC and normal tumor-adjacent tissues and detected the GRAMD4 expression in the samples using RT-PCR and immunohistochemical staining. The correlation between GRAMD4 mRNA expression and clinicopathological features was analyzed. The GRAMD4 mRNA expression in normal liver cell line (LO2) and HCC cell lines (HepG2, Hep3B and SMMC-7721) was detected with RT-PCR.
RESULTS: The mRNA and protein expressions of GRAMD4 in HCC tissues were significantly upregulated compared to those of the normal tumor-adjacent tissues (P<0.05, respectively). Clinicopathological analysis suggested that GRAMD4 mRNA expression was positively associated with tumor size, Edmonson-Steiner classification and advanced TNM stage (P<0.05). Expression of GRAMD4 mRNA in HCC cell lines HepG2, Hep3B, and SMMC-7721 was significantly higher than that in L02 (P<0.05, respectively).
CONCLUSION: The expression of GRAMD4 is up-regulated in HCC cell lines and HCC tissues, and the increased expression is correlated with the clinicopathological characteristics of HCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23388340

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

1.  Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.

Authors:  Anders Berglund; Clarisse Muenyi; Erin M Siegel; Abidemi Ajidahun; Steven A Eschrich; Denise Wong; Leah E Hendrick; Ryan M Putney; Sungjune Kim; D Neil Hayes; David Shibata
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-04-01       Impact factor: 4.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.